Zobrazeno 1 - 5
of 5
pro vyhledávání: '"AKEESHA SHAH"'
Autor:
Shannon S. Wu, Nikhil Joshi, Jonathan Sharrett, Sanjay Rao, Akeesha Shah, Joseph Scharpf, Brian Burkey, Eric D. Lamarre, Brandon Prendes, Allan Siperstein, Joyce Shin, Eren Berber, Judy Jin, Vikram Krishnamurthi, Christian Nasr, Li Hong, David S. Buchberger, Neil Woody, Shlomo A. Koyfman, Jessica L. Geiger
Publikováno v:
JAMA otolaryngology-- headneck surgery.
ImportanceTall cell morphology (TCM) is a rare and aggressive variant of papillary thyroid carcinoma (PTC) that has been associated with poor outcomes; however, the risk factors for worse survival are not well characterized.ObjectiveTo identify progn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::356bc7555306f851853d5c7b50df61b1
https://pubmed.ncbi.nlm.nih.gov/36454559
https://pubmed.ncbi.nlm.nih.gov/36454559
Autor:
Lisa M. Rooper, Abbas Agaimy, Adel Assaad, Munita Bal, Henrietta Eugene, Jeffrey Gagan, Hiro Nonogaki, Doreen N. Palsgrove, Akeesha Shah, Edward Stelow, Robert Stoehr, Lester D.R. Thompson, Ilan Weinreb, Justin A. Bishop
Publikováno v:
The American journal of surgical pathology.
Striated duct adenoma (SDA) is a rare salivary gland neoplasm defined by histologic similarity to normal striated ducts. However, doubt persists about whether SDA represents a genuine entity distinct from canalicular adenoma and if a malignant counte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd8a256eef2206dc23fa764b983deb82
https://pubmed.ncbi.nlm.nih.gov/36510691
https://pubmed.ncbi.nlm.nih.gov/36510691
Autor:
SIDDHARTH KUNTE, JONATHAN SHARETT, WEI WEI, CHRISTIAN NASR, BRANDON PRENDES, ERIC LAMARRE, JAMIE KU, ROBERT R. LORENZ, JOSEPH SCHARPF, BRIAN B. BURKEY, AKEESHA SHAH, NIKHIL JOSHI, JESSICA L. GEIGER
Publikováno v:
Anticancer research. 42(5)
Poorly differentiated thyroid cancer (PDTC) is a rare but aggressive subtype of thyroid cancer that portends a poor prognosis. There remains a paucity of literature on PDTC outcomes. The aim of our study was to evaluate outcomes of PDTC in our tertia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cd0bbb52475a061d85c7b4832a1b5c2
https://pubmed.ncbi.nlm.nih.gov/35489769
https://pubmed.ncbi.nlm.nih.gov/35489769
Publikováno v:
Transplant International. 19:927-936
It is assumed that complement and noncomplement-mediated mechanisms are similarly responsible for Campath-1H-mediated killing of all T-cell subtypes in vivo. However, the differing surface expression of CD52 on T-cell subtypes suggests that may not b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::871df3ab15c67f5e1d6d76a321e2ab53
https://doi.org/10.1111/j.1432-2277.2006.00382.x
https://doi.org/10.1111/j.1432-2277.2006.00382.x
Publikováno v:
Transplant International. 19:749-758
Summary To successfully induce donor-specific tolerance after immune depletion, it is essential to understand the residual and recovering immune system in the context of the depleting agent because the properties of such a recovering immune system di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9caec7b0b70db826af80c5cdc96b28b
https://doi.org/10.1111/j.1432-2277.2006.00350.x
https://doi.org/10.1111/j.1432-2277.2006.00350.x